National Health Investors (NHI) Stock Forecast, Price Target & Predictions
NHI Stock Forecast
National Health Investors stock forecast is as follows: an average price target of $67.25 (represents a -18.30% downside from NHI’s last price of $82.31) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
NHI Price Target
The average price target for National Health Investors (NHI) is $67.25 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $78.00 to $61.00. This represents a potential -18.30% downside from NHI's last price of $82.31.
NHI Analyst Ratings
According to 5 Wall Street analysts, National Health Investors's rating consensus is 'Hold'. The analyst rating breakdown for NHI stock is 0 'Strong Buy' (0.00%), 2 'Buy' (40.00%), 3 'Hold' (60.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
National Health Investors Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 30, 2024 | Michael Lewis | Truist Financial | $78.00 | $80.74 | -3.39% | -5.24% |
| Apr 03, 2024 | Michael Lewis | Truist Financial | $58.00 | $59.89 | -3.16% | -29.53% |
| Mar 12, 2024 | John Kim | National Bank | $67.00 | $59.56 | 12.49% | -18.60% |
| Feb 26, 2024 | Connor Siversky | Wells Fargo | $63.00 | $57.76 | 9.07% | -23.46% |
| Dec 09, 2022 | Tayo Okusanya | National Bank | $58.00 | $56.54 | 2.58% | -29.53% |
| Sep 26, 2022 | - | Truist Financial | $61.00 | $55.44 | 10.03% | -25.89% |
| Apr 18, 2022 | John Kim | BMO Capital | $61.00 | $54.59 | 11.74% | -25.89% |
The latest National Health Investors stock forecast, released on Aug 30, 2024 by Michael Lewis from Truist Financial, set a price target of $78.00, which represents a -3.39% decrease from the stock price at the time of the forecast ($80.74), and a -5.24% decrease from NHI last price ($82.31).
National Health Investors Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 1 | 4 |
| Avg Price Target | $78.00 | $78.00 | $66.50 |
| Last Closing Price | $82.31 | $82.31 | $82.31 |
| Upside/Downside | -5.24% | -5.24% | -19.21% |
In the current month, the average price target of National Health Investors stock is $78.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a -5.24% decrease as opposed to National Health Investors's last price of $82.31. This month's average price target is down 0.00% compared to last quarter, and up 17.29% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 23, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Apr 19, 2024 | BMO Capital | Outperform | Outperform | Hold |
| Mar 19, 2024 | Wedbush | Outperform | Neutral | Downgrade |
| Mar 12, 2024 | BMO Capital | Market Perform | Outperform | Upgrade |
| Feb 26, 2024 | Wedbush | - | Outperform | Upgrade |
| Feb 26, 2024 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| Dec 01, 2023 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| Dec 09, 2022 | Credit Suisse | - | Neutral | Upgrade |
| Jun 21, 2022 | BMO Capital | - | Market Perform | Downgrade |
| Apr 26, 2022 | Zacks Investment Research | - | Hold | Upgrade |
National Health Investors's last stock rating was published by Wells Fargo on Aug 23, 2024. The company gave NHI a "Overweight" rating, the same as its previous rate.
National Health Investors Financial Forecast
National Health Investors Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $67.74M | - | $82.39M | $70.67M | $76.30M | - | $71.33M | $69.67M | $73.83M | $74.33M | $80.89M | $81.24M | $84.30M | $84.17M | $83.08M | $82.19M | $81.68M |
| Avg Forecast | $90.80M | $89.95M | $89.11M | $88.06M | $69.76M | $69.53M | $68.94M | $69.01M | $68.68M | $67.73M | $64.95M | $64.93M | $64.21M | $62.58M | $58.86M | $61.86M | $61.04M | $62.49M | $65.74M | $70.78M | $65.60M | $68.95M | $71.59M | $78.01M | $77.60M | $75.04M | $76.96M | $75.84M | $75.37M | $73.22M |
| High Forecast | $94.46M | $93.58M | $92.71M | $91.62M | $72.57M | $72.34M | $71.72M | $71.80M | $71.45M | $69.47M | $67.57M | $67.55M | $64.34M | $64.12M | $61.23M | $64.36M | $63.50M | $65.01M | $65.74M | $74.57M | $69.11M | $72.64M | $75.43M | $82.19M | $81.76M | $79.07M | $81.09M | $79.91M | $79.41M | $77.14M |
| Low Forecast | $86.21M | $85.40M | $84.61M | $83.61M | $66.23M | $66.01M | $65.45M | $65.52M | $65.21M | $65.96M | $61.67M | $61.65M | $63.95M | $59.24M | $55.88M | $58.73M | $57.95M | $59.33M | $65.74M | $68.57M | $63.55M | $66.80M | $69.36M | $75.58M | $75.18M | $72.70M | $74.56M | $73.48M | $73.02M | $70.93M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | - | 2 | 2 | 2 | 7 | 10 | 10 | 10 | 10 | 6 | 6 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.08% | - | 1.33% | 1.16% | 1.22% | - | 1.01% | 1.06% | 1.07% | 1.04% | 1.04% | 1.05% | 1.12% | 1.09% | 1.10% | 1.09% | 1.12% |
National Health Investors's average Quarter revenue forecast for Dec 23 based on 5 analysts is $64.21M, with a low forecast of $63.95M, and a high forecast of $64.34M. NHI's average Quarter revenue forecast represents a -5.22% decrease compared to the company's last Quarter revenue of $67.74M (Sep 23).
National Health Investors EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | - | 2 | 2 | 2 | 7 | 10 | 10 | 10 | 10 | 6 | 6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $202.00K | - | $64.43M | $31.31M | $47.73M | - | $33.24M | $37.42M | $62.93M | $72.01M | $68.35M | $69.63M | $75.33M | $78.03M | $94.86M | $75.15M | $76.21M |
| Avg Forecast | $70.42M | $69.76M | $69.11M | $68.30M | $54.10M | $53.92M | $53.46M | $53.52M | $53.26M | $52.53M | $50.37M | $57.49M | $49.79M | $48.53M | $45.65M | $52.26M | $47.34M | $48.46M | $50.99M | $55.89M | $62.29M | $53.47M | $55.52M | $76.80M | $60.18M | $73.71M | $59.69M | $58.22M | $75.15M | $56.78M |
| High Forecast | $73.26M | $72.58M | $71.90M | $71.05M | $56.28M | $56.10M | $55.62M | $55.68M | $55.42M | $53.88M | $52.41M | $68.98M | $49.90M | $49.73M | $47.49M | $62.71M | $49.25M | $50.42M | $50.99M | $67.07M | $74.75M | $56.34M | $58.50M | $92.16M | $63.41M | $88.45M | $62.89M | $69.86M | $90.18M | $59.83M |
| Low Forecast | $66.86M | $66.23M | $65.62M | $64.84M | $51.36M | $51.20M | $50.76M | $50.82M | $50.57M | $51.16M | $47.82M | $45.99M | $49.59M | $45.94M | $43.34M | $41.81M | $44.94M | $46.01M | $50.99M | $44.71M | $49.83M | $51.81M | $53.79M | $61.44M | $58.31M | $58.97M | $57.83M | $46.57M | $60.12M | $55.01M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | - | 1.23% | 0.66% | 0.98% | - | 0.59% | 0.60% | 1.18% | 1.30% | 0.89% | 1.16% | 1.02% | 1.31% | 1.63% | 1.00% | 1.34% |
5 analysts predict NHI's average Quarter EBITDA for Dec 23 to be $49.79M, with a high of $49.90M and a low of $49.59M. This is 24550.55% upper than National Health Investors's previous annual EBITDA (Sep 23) of $202.00K.
National Health Investors Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | - | 2 | 2 | 2 | 7 | 10 | 10 | 10 | 10 | 6 | 6 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $29.33M | - | $7.78M | $-10.27M | $23.43M | - | $-1.31M | $-5.14M | $30.81M | $39.18M | $35.33M | $37.14M | $42.59M | $44.37M | $61.02M | $42.04M | $42.76M |
| Avg Forecast | $36.77M | $36.35M | $36.16M | $35.60M | $35.29M | $35.23M | $34.64M | $32.84M | $33.20M | $32.83M | $31.51M | $13.33M | $29.66M | $31.37M | $30.06M | $12.12M | $36.16M | $44.12M | $31.70M | $12.96M | $10.78M | $40.11M | $42.00M | $39.70M | $44.13M | $41.68M | $44.81M | $37.45M | $42.04M | $41.86M |
| High Forecast | $38.70M | $38.26M | $38.06M | $37.47M | $37.14M | $37.08M | $36.46M | $34.56M | $34.94M | $33.13M | $33.17M | $15.99M | $30.20M | $33.54M | $31.64M | $14.54M | $38.06M | $52.94M | $31.70M | $15.55M | $12.94M | $48.13M | $50.41M | $47.64M | $52.95M | $50.01M | $53.77M | $44.94M | $50.45M | $50.23M |
| Low Forecast | $34.36M | $33.96M | $33.78M | $33.26M | $32.97M | $32.92M | $32.36M | $30.68M | $31.02M | $30.68M | $29.44M | $10.66M | $28.83M | $29.19M | $28.08M | $9.69M | $33.78M | $35.30M | $31.70M | $10.37M | $8.62M | $32.09M | $33.60M | $31.76M | $35.30M | $33.34M | $35.85M | $29.96M | $33.63M | $33.49M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.93% | - | 0.64% | -0.28% | 0.53% | - | -0.10% | -0.48% | 0.77% | 0.93% | 0.89% | 0.84% | 1.02% | 0.99% | 1.63% | 1.00% | 1.02% |
National Health Investors's average Quarter net income forecast for Dec 23 is $29.66M, with a range of $28.83M to $30.20M. NHI's average Quarter net income forecast represents a 1.12% increase compared to the company's last Quarter net income of $29.33M (Sep 23).
National Health Investors SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | - | 2 | 2 | 2 | 7 | 10 | 10 | 10 | 10 | 6 | 6 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.43M | - | $5.78M | $5.17M | $4.83M | - | $9.93M | $3.90M | $3.77M | $3.55M | $8.12M | $3.60M | $3.03M | $3.28M | $4.64M | $3.71M | $2.84M |
| Avg Forecast | $5.54M | $5.49M | $5.44M | $5.38M | $4.26M | $4.24M | $4.21M | $4.21M | $4.19M | $4.13M | $3.96M | $15.75M | $3.92M | $3.82M | $3.59M | $14.32M | $3.73M | $5.39M | $4.01M | $15.32M | $6.50M | $4.90M | $3.80M | $9.12M | $4.28M | $2.96M | $3.31M | $2.85M | $3.71M | $2.78M |
| High Forecast | $5.77M | $5.71M | $5.66M | $5.59M | $4.43M | $4.42M | $4.38M | $4.38M | $4.36M | $4.24M | $4.12M | $18.90M | $3.93M | $3.91M | $3.74M | $17.19M | $3.88M | $6.47M | $4.01M | $18.38M | $7.80M | $5.88M | $4.56M | $10.95M | $5.14M | $3.55M | $3.98M | $3.42M | $4.45M | $3.34M |
| Low Forecast | $5.26M | $5.21M | $5.16M | $5.10M | $4.04M | $4.03M | $3.99M | $4.00M | $3.98M | $4.03M | $3.76M | $12.60M | $3.90M | $3.62M | $3.41M | $11.46M | $3.54M | $4.31M | $4.01M | $12.25M | $5.20M | $3.92M | $3.04M | $7.30M | $3.42M | $2.37M | $2.65M | $2.28M | $2.97M | $2.23M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.16% | - | 0.40% | 1.39% | 0.90% | - | 0.65% | 0.60% | 0.77% | 0.93% | 0.89% | 0.84% | 1.02% | 0.99% | 1.63% | 1.00% | 1.02% |
National Health Investors's average Quarter SG&A projection for Dec 23 is $3.92M, based on 5 Wall Street analysts, with a range of $3.90M to $3.93M. The forecast indicates a -11.53% fall compared to NHI last annual SG&A of $4.43M (Sep 23).
National Health Investors EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 5 | 4 | 2 | 2 | 1 | 1 | 1 | - | 2 | 2 | 2 | 7 | 10 | 10 | 10 | 10 | 6 | 6 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.68 | - | $0.18 | $-0.24 | $0.53 | - | $-0.03 | $-0.11 | $0.67 | $0.85 | $0.78 | $0.83 | $0.95 | $0.99 | $1.37 | $0.95 | $0.98 |
| Avg Forecast | $0.84 | $0.83 | $0.83 | $0.82 | $0.81 | $0.81 | $0.80 | $0.75 | $0.76 | $0.75 | $0.72 | $0.68 | $0.68 | $0.72 | $0.69 | $0.66 | $0.83 | $0.77 | $0.73 | $0.63 | $0.93 | $0.86 | $0.89 | $0.89 | $1.01 | $0.90 | $1.00 | $0.95 | $0.94 | $0.95 |
| High Forecast | $0.89 | $0.88 | $0.87 | $0.86 | $0.85 | $0.85 | $0.84 | $0.79 | $0.80 | $0.76 | $0.76 | $0.71 | $0.69 | $0.77 | $0.73 | $0.69 | $0.87 | $0.81 | $0.73 | $0.67 | $0.99 | $0.93 | $0.95 | $0.95 | $1.08 | $0.96 | $1.07 | $1.02 | $1.01 | $1.02 |
| Low Forecast | $0.79 | $0.78 | $0.78 | $0.76 | $0.76 | $0.76 | $0.74 | $0.70 | $0.71 | $0.70 | $0.68 | $0.63 | $0.66 | $0.67 | $0.64 | $0.62 | $0.78 | $0.72 | $0.73 | $0.60 | $0.89 | $0.83 | $0.85 | $0.85 | $0.97 | $0.86 | $0.96 | $0.92 | $0.91 | $0.91 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | - | 0.27% | -0.29% | 0.69% | - | -0.05% | -0.12% | 0.77% | 0.96% | 0.88% | 0.82% | 1.06% | 0.99% | 1.43% | 1.01% | 1.03% |
According to 5 Wall Street analysts, National Health Investors's projected average Quarter EPS for Dec 23 is $0.68, with a low estimate of $0.66 and a high estimate of $0.69. This represents a 0.11% increase compared to NHI previous annual EPS of $0.68 (Sep 23).
National Health Investors Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CHCT | Community Healthcare Trust | $16.22 | $36.50 | 125.03% | Buy |
| HR | Healthcare Realty Trust | $17.95 | $19.00 | 5.85% | Buy |
| SBRA | Sabra Health Care REIT | $17.25 | $16.83 | -2.43% | Hold |
| VTR | Ventas | $62.86 | $60.30 | -4.07% | Buy |
| OHI | Omega Healthcare Investors | $39.64 | $35.73 | -9.86% | Buy |
| NHI | National Health Investors | $82.31 | $67.25 | -18.30% | Hold |
NHI Forecast FAQ
Is National Health Investors a good buy?
No, according to 5 Wall Street analysts, National Health Investors (NHI) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 40.00% of NHI's total ratings.
What is NHI's price target?
National Health Investors (NHI) average price target is $67.25 with a range of $61 to $78, implying a -18.30% from its last price of $82.31. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will National Health Investors stock go up soon?
According to Wall Street analysts' prediction for NHI stock, the company can go down by -18.30% (from the last price of $82.31 to the average price target of $67.25), down by -5.24% based on the highest stock price target, and down by -25.89% based on the lowest stock price target.
Can National Health Investors stock reach $120?
NHI's average twelve months analyst stock price target of $67.25 does not support the claim that National Health Investors can reach $120 in the near future.
What is National Health Investors's current price target trend?
1 Wall Street analyst forecast a $78 price target for National Health Investors (NHI) this month, down -5.24% from its last price of $82.31. Compared to the last 3 and 12 months, the average price target decreased by -5.24% and decreased by -19.21%, respectively.
What are National Health Investors's analysts' financial forecasts?
National Health Investors's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $277.24M (high $288.43M, low $263.22M), average EBITDA is $215.01M (high $223.69M, low $204.14M), average net income is $138M (high $145.24M, low $128.92M), average SG&A $16.92M (high $17.61M, low $16.07M), and average EPS is $3.17 (high $3.33, low $2.96). NHI's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $357.92M (high $372.37M, low $339.82M), average EBITDA is $277.58M (high $288.79M, low $263.55M), average net income is $144.89M (high $152.5M, low $135.37M), average SG&A $21.85M (high $22.73M, low $20.74M), and average EPS is $3.33 (high $3.5, low $3.11).
Did the NHI's actual financial results beat the analysts' financial forecasts?
Based on National Health Investors's last annual report (Dec 2022), the company's revenue was $278.19M, beating the average analysts forecast of $260.05M by 6.98%. Apple's EBITDA was $151.99M, missing the average prediction of $202.68M by -25.01%. The company's net income was $23.06M, missing the average estimation of $124.94M by -81.54%. Apple's SG&A was $25.32M, missing the average forecast of $28.45M by -10.99%. Lastly, the company's EPS was $0.52, missing the average prediction of $2.96 by -82.43%. In terms of the last quarterly report (Sep 2023), National Health Investors's revenue was $67.74M, beating the average analysts' forecast of $62.58M by 8.24%. The company's EBITDA was $202K, missing the average prediction of $48.53M by -99.58%. National Health Investors's net income was $29.33M, missing the average estimation of $31.37M by -6.50%. The company's SG&A was $4.43M, beating the average forecast of $3.82M by 15.97%. Lastly, the company's EPS was $0.68, missing the average prediction of $0.72 by -5.56%